EMS SA - Company Profile
Powered by 
All the data and insights you need on EMS SA in one report.
$295
- Save hours of research time and resources with
our up-to-date EMS SA Strategy Report
- Understand EMS SA position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
EMS SA (EMS), a subsidiary of Grupo NC, is a pharmaceutical company that focuses on the development of products for the improvement of the health and well-being of the population. The company operates in the segments of medical prescription, generics, branded pharmaceuticals, manufacturing products, OTC, and hospitals. Its major product portfolio includes drugs in the therapeutic areas of anti-inflammatories, analgesics, antihypertensives, anthelmintics, antidiabetics, antibiotics, anti-ulcers, topical corticosteroids, and anti-flu. EMS has production units in Sao Bernardo do Campo, Jaguariuna and Hortolandia in Sao Paulo; Novamed, Manaus in Amazonas; and Brasilia in Federal District. The company is certified by European Medicines Agency. EMS is headquartered in Hortolandia, Brazil.
Headquarters
Brazil
Address
Rod Journalist Francisco Aguirre Proenca, 08 KM, Neighborhood Chacara Assay, Hortoladia, Sao Paulo, 13186-901
Website
www.ems.com.br
No of Employees
5,000
Industry
Pharmaceuticals and Healthcare
EMS SA premium industry data and analytics
Products and Services
| Products | Brands |
|---|---|
| Generic Drugs | Gerovital |
| Prescription Drugs | Sigmasporin |
| Over The Counter Drugs | Energil C |
| XYZ | XYZ |
| XYZ | XYZ |
| XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2023 | Plans/Strategy | In May, the company announced its plans to acquire Dermacyd and Lactacyd brands from Sanofi. |
| 2021 | Acquisitions/Mergers/Takeovers | In July, the company acquired the commercial rights for production of the brand Caladryl from Cellera Farma expanding its OTC products portfolio. |
| 2021 | New Products/Services | In May, the company launched Rivaroxaban in 10gm, 15gm and 20gm dosage tablets, for prevention from strokes, thrombosis and embolism, on the occasion of National Day of Generic Medicine. |
Competitor Comparison
| Key Parameters | EMS SA | Eurofarma Laboratorios SA | Ache Laboratorios Farmaceuticos SA | Biotecnica Industria E Comercio Ltda | Intrials Research Clinical. |
|---|---|---|---|---|---|
| Headquarters | Brazil | Brazil | Brazil | Brazil | Brazil |
| City | Hortoladia | Sao Paulo City | Guarulhos | Varginha | Sao Paulo |
| State/Province | Sao Paulo | Sao Paulo | Sao Paulo | Minas Gerais | - |
| No. of Employees | 5,000 | 8,100 | 5,144 | - | - |
| Entity Type | Private | Private | Private | Private | Private |
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Marcus Sanchez | Vice President | Senior Management | - | - |
| Viseu Fernandes | Director | Non Executive Board | - | - |
| Josemara Tsuruoka | Institutional Marketing Manager | Operational Management | - | - |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer